September 21, 2024 – The 16th China Bio-Industry Conference, held in Guangzhou Bio-island from September 19 to 21, 2024, brought together leading scholars and industry experts from different bio-industry sectors. Chaired by Gao Fu, President of the Chinese Society of Biological Engineering, the event marked the inauguration of the Biomedical Data Research Institute. Led by the Chinese Society of Bioengineering, this new institute will focus on biomedical data research and technology transformation, aiming to build a comprehensive big data platform for next-generation drug R&D and clinical applications.
The Biomedical Data Research Institute aims to utilize biomedical data from related data holders and transform these data into functional tools to assist scientific research purposes. The institute is looking to create a robust big-data platform that will support the development of innovative drugs and enhance clinical outcomes.
Changfu Cheng, Ph.D., founder of X-CUTAG, attended the conference and signed a strategic cooperation agreement with the Biomedical Data Research Institute. This partnership will facilitate collaborative research and innovation in biomedical data, accelerating the development of new therapies and translating cutting-edge research into industrial drivers.
The 16th China Bio-Industry Conference served as a key platform for knowledge sharing and collaboration among China's biopharmaceutical companies. The establishment of the Biomedical Data Research Institute marks a new era for data-driven research in China's biomedical sector, with the potential to drive intelligent and rapid growth in the industry. Through this collaboration, X-CUTAG aims to enhance drug innovation and clinical transformation, contributing to the high-quality development of biopharmaceuticals.
About X-CUTAG
X-CUTAG is a leading biotechnology company focused on the development of innovative drugs using advanced "deuterium +" technology. The company's mission is to enhance the safety, efficacy, and pharmacokinetic properties of new drugs, thereby improving patient care and treatment options.
About the Biomedical Data Research Institute
The Biomedical Data Research Institute, led by the Chinese Society of Bioengineering, is dedicated to the research and application of biomedical data. The institute aims to build a comprehensive big data platform to support drug R&D and clinical needs, and shepherds the advancement of the biopharmaceutical industry via data supports in China.
